Integra LifeSciences [IART] vs Abbott Laboratories [ABT] Detailed Stock Comparison

Integra LifeSciences Holdings Corporation

NASDAQ
Loading...

Abbott Laboratories

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Integra LifeSciences Holdings Corporation wins in 6 metrics, Abbott Laboratories wins in 13 metrics, with 0 ties. Abbott Laboratories appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Integra LifeSciences Holdings Corporation Abbott Laboratories Better
P/E Ratio (TTM) 66.48 25.97 Abbott Laboratories
Price-to-Book Ratio 0.79 3.09 Integra LifeSciences Holdings Corporation
Debt-to-Equity Ratio 195.01 26.79 Abbott Laboratories
PEG Ratio -0.61 -1.41 Integra LifeSciences Holdings Corporation
EV/EBITDA 8.70 13.74 Integra LifeSciences Holdings Corporation
Profit Margin (TTM) -31.58% 13.90% Abbott Laboratories
Operating Margin (TTM) 12.44% 16.50% Abbott Laboratories
EBITDA Margin (TTM) 12.44% 16.50% Abbott Laboratories
Return on Equity -39.90% 12.36% Abbott Laboratories
Return on Assets (TTM) 2.39% 7.52% Abbott Laboratories
Free Cash Flow (TTM) $-45.25M $7.40B Abbott Laboratories
Dividend Yield N/A 1.97% N/A
1-Year Return 26.70% -35.92% Integra LifeSciences Holdings Corporation
Price-to-Sales Ratio (TTM) 0.50 3.57 Integra LifeSciences Holdings Corporation
Enterprise Value $2.59B $166.96B Abbott Laboratories
EV/Revenue Ratio 1.58 3.70 Integra LifeSciences Holdings Corporation
Gross Profit Margin (TTM) 50.78% N/A N/A
Revenue per Share (TTM) $21 $26 Abbott Laboratories
Earnings per Share (Diluted) $-6.74 $3.57 Abbott Laboratories
Beta (Stock Volatility) 1.07 0.78 Abbott Laboratories
Short % of Float 15.66% 1.53% Abbott Laboratories

Integra LifeSciences Holdings Corporation vs Abbott Laboratories Stock Performance Analysis

Loading Price Chart...

IART
ABT

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Integra LifeSciences Holdings Corporation2.74%5.99%51.17%52.46%19.35%34.05%
Abbott Laboratories0.02%1.53%-0.63%-23.43%-30.57%-29.95%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Integra LifeSciences Holdings Corporation26.70%-58.81%-76.26%-57.80%-32.49%-15.84%
Abbott Laboratories-35.92%-17.85%-21.68%118.48%249.25%313.73%

Performance & Financial Health Analysis: Integra LifeSciences Holdings Corporation vs Abbott Laboratories

MetricIARTABT
Market Information
Market Cap i$804.31M$160.70B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i754,94913,495,583
90 Day Avg. Volume i818,79312,934,461
Last Close$16.10$86.99
52 Week Range$8.70 - $16.70$81.97 - $139.06
% from 52W High-3.59%-37.44%
All-Time High$77.40 (Apr 26, 2021)$142.60 (Dec 27, 2021)
% from All-Time High-79.20%-39.00%
Growth Metrics
Quarterly Revenue Growth-0.02%0.08%
Quarterly Earnings Growth-0.02%-0.19%
Financial Health
Profit Margin (TTM) i-0.32%0.14%
Operating Margin (TTM) i0.12%0.17%
Return on Equity (TTM) i-0.40%0.12%
Debt to Equity (MRQ) i195.0126.79
Cash & Liquidity
Book Value per Share (MRQ)$13.40$30.02
Cash per Share (MRQ)$3.38$5.14
Operating Cash Flow (TTM) i$50.38M$10.80B
Levered Free Cash Flow (TTM) i$44.46M$13.77B
Dividends
Last 12-Month Dividend Yield iN/A1.97%
Last 12-Month Dividend iN/A$2.40

Valuation & Enterprise Metrics Analysis: Integra LifeSciences Holdings Corporation vs Abbott Laboratories

MetricIART (Apr 24, 2026)ABT (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i66.4825.97
Forward P/E i4.1115.29
PEG Ratio i-0.61-1.41
Price to Sales (TTM) i0.503.57
Price to Book (MRQ) i0.793.09
Market Capitalization
Market Capitalization i$804.31M$160.70B
Enterprise Value i$2.59B$166.96B
Enterprise Value Metrics
Enterprise to Revenue i1.583.70
Enterprise to EBITDA i8.7013.74
Risk & Other Metrics
Beta i1.070.78
Book Value per Share (MRQ) i$13.40$30.02

Financial Statements Comparison: Integra LifeSciences Holdings Corporation vs Abbott Laboratories

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricIART (2025)ABT (2025)
Revenue/Sales i1.64B44.33B
Cost of Goods Sold i803.63M19.32B
COGS % of Revenue i49.1%43.6%
Gross Profit i831.62M25.01B
Gross Margin i50.9%56.4%
Research & Development i98.97M2.94B
Operating Income (EBIT) i18.00M8.05B
Operating Margin i1.1%18.2%
EBITDA i185.95M12.03B
EBITDA Margin i11.4%27.1%
Pre-Tax Income i-563.50M8.47B
Pre-Tax Income % of Revenue i-34.5%19.1%
Income Tax i-47.03M1.94B
Income Tax % of Revenue i-2.9%4.4%
Net Income (Profit) i-516.47M6.52B
Profit Margin i-31.6%14.7%

Balance Sheet & Liquidity Metrics

MetricIART (2025)ABT (2025)
Cash & Equivalents i235.05M8.52B
Total Current Assets i1.16B26.00B
Total Current Assets % of Revenue i70.9%58.6%
Total Current Liabilities i455.98M16.50B
Total Current Liabilities % of Revenue i27.9%37.2%
Long-Term Debt i1.89B10.83B
Long-Term Debt % of Revenue i115.7%24.4%
Total Shareholders Equity i1.04B52.77B
Retained Earnings i423.44M49.78B
Retained Earnings % of Revenue i25.9%112.3%
Property, Plant & Equipment i140.57M17.57B

Cash Flow Statement Comparison

MetricIART (2025)ABT (2025)
Operating Cash Flow i-458.67M10.80B
Operating Cash Flow % of Revenue i-28.0%24.4%
Capital Expenditures i-81.44M-2.17B
Free Cash Flow i-45.25M7.40B
FCF Margin i-2.8%16.7%
Debt Repayment i-669.89M-1.50B
Common Stock Repurchase i-221,000-893.00M

Short Interest & Institutional Ownership Analysis

MetricIARTABT
Shares Short i8.86M23.83M
Short Ratio i10.731.93
Short % of Float i15.66%1.53%
Shares Outstanding i77.89M1.74B
Float Shares i58.96M1.73B
% Held by Insiders i14.38%0.54%
% Held by Institutions i97.96%82.23%
% Held by Public i-12.34%17.23%

Dividend Analysis & Yield Comparison: Integra LifeSciences Holdings Corporation vs Abbott Laboratories

MetricIARTABT
Last 12-Month Dividend iN/A$2.40
Last 12-Month Dividend Yield iN/A1.97%
3-Year Avg Annual Dividend iN/A$2.24
3-Year Avg Dividend Yield iN/A0.50%
3-Year Total Dividends iN/A$6.72
Ex-Dividend DateN/AJan 15, 2026